华中科技大学学报(医学版) ›› 2026, Vol. 55 ›› Issue (1): 82-90.doi: 10.3870/j.issn.1672-0741.25.06.014

• 实验研究 • 上一篇    下一篇

mTORC1通过β-TrCP调控TPP1蛋白的稳定性*

孟志伟1, 张瑞怀1, 闫先航1, 陈耀2, 周小明1,2△   

  1. 1江苏大学医学院基础医学系, 镇江 212013
    2依诺赞(江苏)生物科技有限公司, 南京 210032
  • 收稿日期:2025-06-12 出版日期:2026-02-15 发布日期:2026-02-10
  • 通讯作者: E-mail: zhouxm@ujs.edu.cn
  • 作者简介:孟志伟,男,2000年生,硕士研究生,E-mail: zwmeng2353@163.com
  • 基金资助:
    *国家自然科学基金资助项目(No.81571546)

Biochemical Regulation of TPP1 Protein Stability by mTORC1 via β-TrCP

Meng Zhiwei, Zhang Ruihuai, Yan Xianhang et al   

  1. Medical School, Jiangsu University, Zhenjiang 212013, China
  • Received:2025-06-12 Online:2026-02-15 Published:2026-02-10
  • Contact: E-mail: zhouxm@ujs.edu.cn

摘要: 目的 探讨雷帕霉素机制性靶蛋白复合物1(mechanistic target of rapamycin complex 1,mTORC1)通过β-转导素重复序列蛋白(β-TrCP)对三肽基肽酶1(tripeptidyl peptidase 1,TPP1)蛋白稳定性的调控作用。方法 利用免疫共沉淀、谷胱甘肽巯基转移酶沉降技术(GST Pull-down)以及蛋白质免疫印迹技术(Western blot)探究TPP1与mTORC1和(或)β-TrCP之间的相互作用;利用不同营养应激或雷帕霉素调节体外培养细胞的mTORC1活性,通过Western blot观察TPP1蛋白表达水平,或通过定量聚合酶链式反应(quantitative real-time PCR,qPCR)观察TPP1转录水平;利用蛋白酶体或Cullin neddylation抑制剂探究TPP1蛋白降解是否由蛋白酶体和Cullin依赖性的E3泛素连接酶介导;利用DNA点突变(site-directed DNA mutagenesis)技术将TPP1上潜在的β-TrCP识别的磷酸化降解决定子(phosphodegron)序列中的丝氨酸(S)突变为丙氨酸(A);利用慢病毒介导的shRNA技术静默β-TrCP或Cullin1基因的表达;利用Western blot检测TPP1磷酸化以及泛素化水平,并验证Phosphodegron中的两个丝氨酸位点对其泛素化的重要性;利用体外TPP1活性实验探究Phosphodegron突变是否会影响TPP1活性。结果 TPP1与mTORC1或β-TrCP均存在相互作用;TPP1蛋白水平与mTORC1活性成反比,且蛋白水平的变化并非由转录水平改变引起;蛋白酶体被抑制或β-TrCP被敲低后,TPP1蛋白水平升高。体外激酶实验表明TPP1可以被mTORC1磷酸化,体内泛素化实验表明TPP1可以被β-TrCP泛素化;TPP1的Phosphodegron突变不会影响TPP1活性。结论 mTORC1通过磷酸化TPP1促进其与β-TrCP的特异性结合,进而导致TPP1的泛素化以及蛋白酶体降解。

关键词: mTORC1, β-TrCP, TPP1, 泛素-蛋白酶体系统

Abstract: Objective To explore the regulatory role of mechanistic target of rapamycin complex 1(mTORC1)on the protein stability of triphenyl peptidase 1(TPP1)through β-TrCP. Methods Interactions between TPP1 and mTORC1 or β-TrCP were investigated via GST Pull-down,coimmunoprecipitation and Western blotting.The cells were cultured under various nutrient stress conditions or treated with rapamycin to inhibit mTORC1 activity.TPP1 protein expression was assessed via Western blotting,while TPP1 transcriptional levels were measured via qPCR.Proteasome or cullin neddylation inhibitors were used to determine whether TPP1 degradation is mediated by the proteasome and Cullin-dependent E3 ubiquitin ligases.Putative β-TrCP recognition phosphodegron motifs in TPP1 were mutated via site-directed mutagenesis,replacing serine(S)residues with alanine(A).Lentivirus-delivered shRNA was employed to silence β-TrCP or Cullin1 gene expression.TPP1 phosphorylation and ubiquitination levels were detected by Western blotting,and the essential role of two serine residues within the phosphodegron in its ubiquitination was functionally validated.In vitro TPP1 activity assays were performed to assess whether phosphodegron mutations affect TPP1 enzymatic activity. Results TPP1 interacted with both mTORC1 and β-TrCP.TPP1 protein levels were negatively correlated with mTORC1 activity,and this regulation was not due to transcriptional changes.Inhibition of the proteasome or knockdown of β-TrCP increased TPP1 protein levels.In vitro kinase and in vivo ubiquitination assays confirmed that TPP1 was phosphorylated by mTORC1 and ubiquitinated by β-TrCP.Mutations in the TPP1 phosphodegron did not affect its enzymatic activity. Conclusion mTORC1 phosphorylates TPP1,promoting its specific binding to β-TrCP,leading to TPP1 ubiquitination and subsequent proteasomal degradation.

Key words: mTORC1, β-TrCP, TPP1, ubiquitin-proteasome system

中图分类号: